Candiduria—Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital

Subramanian Pramodhini; Sreenivasan Srirangaraj; Joshy Maducolil Easow

doi:10.1055/s-0041-1730880

Journal of Laboratory Physicians, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(03): 231-237
DOI: 10.1055/s-0041-1730880

Original Article

Candiduria—Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital

Subramanian Pramodhini

¹Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (deemed to be university), Puducherry, India

,

Sreenivasan Srirangaraj

¹Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (deemed to be university), Puducherry, India

,

Joshy Maducolil Easow

¹Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (deemed to be university), Puducherry, India

› Institutsangaben

Abstract

Background The increased incidence of candiduria in hospitalized patients is due to the use of indwelling devices, long-term antibiotics, parenteral nutrition, and immunocompromised status of the patient. In this study, an attempt was made to speciate, characterize, and determine the antifungal susceptibility pattern of Candida isolated from urinary tract infections (UTIs).

Materials and Methods A total of 70 Candida isolates were obtained from urine samples. The isolated Candida species were studied for the production of virulence factors like phospholipase, protease activities, hemolysin, and biofilm production. Antifungal susceptibility testing of the isolated yeasts was done using Mueller-Hinton agar supplemented with 0.5 mg/mL methylene blue by E-test method for amphotericin B, fluconazole, caspofungin, and voriconazole.

Results Out of 70 isolates, Candida tropicalis was the most frequently isolated species (65.7%), followed by Candida albicans (14.3%), Candida glabrata (7.1%), Candida krusei (5.7%), Candida parapsilosis (4.3%), and Candida dubliniensis (2.9%). A total of 37.1% were biofilm producers, 62.9% showed proteinase activity, 38.6% were phospholipase positive, and 58.6% isolates showed hemolytic activity. Antifungal susceptibility profile of Candida species showed 38.6, 25.7, 15.7, and 12.9% resistance to amphotericin B, fluconazole, caspofungin, and voriconazole, respectively.

Conclusion A rising trend in isolation of non-albicans Candida from urinary isolates was noticed, which was statistically significant when comparing catheterized and noncatheterized urinary isolates from our study. However, there was no statistically significant difference when different virulence factor expressions were compared among Candida spp. isolated from catheterized and noncatheterized urinary samples. Due to this rise in non-albicans Candida species causing UTI that are intrinsically resistant to certain antifungal agents like azoles and increasing incidence of antifungal resistance, it is essential to monitor the antifungal susceptibility profile of Candida species causing candiduria.

Keywords

virulence - biofilm - proteinase - phospholipase - hemolysin

Volltext

Referenzen

References
1 Kauffman CA, Fisher JF, Sobel JD, Newman CA. Candida urinary tract infections—diagnosis. Clin Infect Dis 2011; 52 (Suppl. 06) S452-S456
2 Agarwal S, Manchanda V, Verma N, Bhalla P. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol 2011; 29 (02) 172-177
3 Larone DH. Medically Important Fungi: A Guide to Identification. 5th ed. Washington DC: ASM press 2011
4 Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 2007; 56 (Pt 10) 1393-1398
5 Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22 (03) 201-207
6 Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J Glob Infect Dis 2011; 3 (01) 4-8
7 Staib F. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia 1965; 4 (03) 187-193
8 Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun 1994; 62 (11) 5154-5156
9 Branchini ML, Pfaller MA, Rhine-Chalkberg J, Frempong T, Isenberg HD. Genotype variation and slime production among blood and catheter isolates of C. parapsilosis . J Clin Microbiol 1994; 32: 452-456
10 Clinical and Laboratory Standards Institute. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. 3rd ed. CLSI document M44. Wayne, PA: Clinical and Laboratory Standards Institute 2020
11 Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001; 32 (11) 1602-1607
12 Guler S, Ural O, Findik D, Arslan U. Risk factors for nosocomial candiduria. Saudi Med J 2006; 27 (11) 1706-1710
13 Gharanfoli A, Mahmoudi E, Torabizadeh R, Katiraee F, Faraji S. Isolation, characterization, and molecular identification of Candida species from urinary tract infections. Curr Med Mycol 2019; 5 (02) 33-36
14 Marak MB, Dhanashree B. Isolated from Clinical Samples. Antifungal susceptibility and biofilm production of Candida spp. Int J Microbiol 2018; 2018: 7495218
15 Sajjan AC, Mahalakshmi VV, Hajare D. Prevalence and antifungal susceptibility of Candida species isolated from patients attending tertiary care hospital. IOSR J Dent Med Sci 2014; 13 (05) 44-49
16 Passos XS, Sales WS, Maciel PJ. et al Candida colonization in intensive care unit patients’ urine. Mem Inst Oswaldo Cruz 2005; 100 (08) 925-928
17 Tomczak H, Szałek E, Grześkowiak E. The problems of urinary tract infections with Candida spp. aetiology in women. Postepy Hig Med Dosw 2014; 68: 1036-1039
18 Jain M, Dogra V, Mishra B, Thakur A, Loomba PS, Bhargava A. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J Pathol Microbiol 2011; 54 (03) 552-555
19 Lata RP, Jayshri DP, Palak B, Sanjay DR, Parul DS. Prevalence of Candida infection and its antifungal susceptibility pattern in tertiary care hospital, Ahmedabad. Natl J Med Res 2012; 2: 439-441
20 Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev 2010; 23 (02) 253-273
21 Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48 (06) 365-377
22 Alenzi FQB. Virulence factors of Candida species isolated from patients with urinary tract infection and obstructive uropathy. Pak J Med Sci 2016; 32 (01) 143-146
23 Borst A, Fluit AC. High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J Med Microbiol 2003; 52 (Pt 11) 971-974
24 Sachin CD, Ruchi K, Santosh S. In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens. Int J Med Biomed Res 2012; 1 (02) 153-157
25 Udayalaxmi JS, Jacob S, D’Souza D. Comparison between virulence factors of Candida albicans and non-Albicans species of Candida isolated from genitourinary tract. J Clin Diagn Res 2014; 8 (11) DC15-DC17
26 Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In vitro susceptibilities of Candida albicans isolates to antifungal agents in Tokat, Turkey. Jundishapur J Microbiol 2015; 8 (09) e28057